Dr. Daniel P. Judge

Dr. Tedford is a Professor of Medicine/Cardiology and holds the Dr. Peter C. Gazes Endowed Chair in Heart Failure at the Medical University of South Carolina (MUSC) in Charleston, SC. He currently serves as the section head of heart failure and medical director of cardiac transplantation. He also established and directs the Advanced Heart Failure and Transplant Fellowship Program at MUSC. Dr. Tedford is an internationally recognized clinical researcher and has published over 200 peer-reviewed original research manuscripts, invited expert reviews, editorials and book chapters. His research efforts are focused on hemodynamic assessment of right ventricle function and its interaction with the pulmonary circulation and left heart. This research spans the fields of pulmonary hypertension, left heart disease, exercise physiology, hemodynamics, systemic sclerosis and mechanical circulatory support. He participates on several scientific advisory boards, clinical trial steering committees, and serves as a hemodynamic core laboratory for clinical pharmaceutical trials. He is co-chair of the PH due to left heart disease task force for 7^th^ World Symposium on Pulmonary Hypertension. He is a deputy editor for the *Journal of Heart and Lung Transplantation* and serves on the editorial board for *Circulation: Heart Failure CHEST*and *JACC: Heart* *Failure.*. Dr. Tedford is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Heart Failure with Preserved Ejection Fraction (HFpEF), Pulmonary Hypertension, Scleroderma, Heart Transplant, and Lung Transplant. Dr. Tedford is currently accepting new patients.

Dr. Sheldon E. Litwin is a cardiologist with nationally recognized expertise in advanced cardiac imaging and its use in the diagnosis of heart disease and treatment of patients with heart disease. Dr. Litwin is board-certified in general cardiology, nuclear cardiology, echocardiography, and cardiovascular computed tomography (CT). He was recognized in 2014 in America's Top Doctors (Castle Connolly Medical Ltd.). He is a strong proponent of preventive cardiology and has a longstanding interest in weight loss as prevention and treatment for cardiovascular disease. He is an avid outdoorsman and exercise advocate who is passionate about caring for active adults who participate in sports or recreational exercise. Prior to coming to MUSC Health, Dr. Litwin was chief of the division of cardiology at Georgia Regents University from 2011 to 2014 and director of cardiac imaging at the University of Utah from 1993 to 2011. Dr. Litwin is involved in clinical trials using new therapies for heart failure with preserved ejection fraction (HFpEF). He has published more than 100 scientific papers and serves on several editorial boards and national committees.Dr. Litwin's medical degree was awarded by Washington University School of Medicine. He completed a residency at the University of Arizona and completed a cardiology fellowship at Beth Israel Hospital, Harvard Medical School. Dr. Litwin is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Heart Failure with Preserved Ejection Fraction (HFpEF), Cardiomyopathy, Hypertrophic Cardiomyopathy (HCM), Gastric Bypass, and Aortic Valve Replacement. Dr. Litwin is currently accepting new patients.

Dr. Scalea is a board-certified surgeon specializing in kidney, pancreas, liver, and islet cell transplantation. Dr. Scalea's patient care philosophy is to treat his patients with a meticulous focus on excellence and compassionate care. His clinical area of expertise is in abdominal organ transplantation, with a special interest in kidney, pancreas, and islet cell transplantation. Dr. Scalea has achieved outstanding results in his simultaneous kidney and pancreas (SPK) transplant recipients. At MUSC Health, he is the Surgical Director of the Kidney Transplant Program and the Director of Hepatology, Nephrology, and Transplant ICCE Quality and Innovation.Dr. Scalea's research interests focus on improving outcomes and access to care for patients needing life-saving transplantation and researching strategies to achieve immune tolerance in allogeneic solid organ transplantation. He received international notoriety in 2019 for pioneering drones for organ transplants. As the inaugural Vice Chair of Surgery for Innovation, Dr. Scalea will expand his experience in clinical medicine, academic leadership, commercialization, and innovation to help translate innovative ideas from the laboratory to industry.Dr. Scalea received his medical degree and surgical training from the University of Maryland and completed his transplant fellowship at the University of Wisconsin and his post-doctoral fellowship at the Harvard Medical School, Transplantation Biology Research Center.When not in the clinic or laboratory, Dr. Scalea enjoys painting and performing music. His artworks are currently on display in Baltimore and Washington, D.C. Dr. Scalea is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Chronic Antibody-Mediated Rejection, Polycystic Kidney Disease, End-Stage Renal Disease (ESRD), Pancreas Transplant, and Kidney Transplant. Dr. Scalea is currently accepting new patients.